KMXCarMax, Inc.
- Next report
- Dec 17
- Thursday, in 35 days · time not announced yet
- EPS expected
- $0.42
- quarter ending Nov 30, 2026
- Last result
- $1.31Beat
- vs $0.94 expected on Jun 19
- Stock move on it
- −2.35%
- one session
- Price
- $52.58
- −2.43% today · $8.39B cap
Past and upcoming reports
2
| Dec 17, 2026 | Nov 30, 2026 | Time not announced yet | $0.42 | not yet | |
| Jun 19, 2026 | May 31, 2026 | Time not given | $0.94 | Beat$1.31 | −2.35% |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 19, 2026 report
CarMax Q1 EPS beats by 39%, shares dip 2.3% amid mixed growth outlook
CarMax reported Q1 EPS of $1.31 versus $0.94 estimate, a 39% beat. shares fell 2.3% post-earnings. Despite strong EPS, growth metrics remain weak and valuation is below sector average. Institutional ownership is high at 108%, but leverage and margins are concerns. Investors should monitor upcoming revenue and EPS growth trends for directional clarity.
Reported against expected
CarMax reported EPS of $1.31, beating the $0.94 consensus estimate by 38.8%.
Guidance
No explicit forward guidance was provided. growth metrics remain weak with negative EPS growth trends.
How the stock reacted
Shares declined 2.3% to $52.40 on heavy volume following the earnings beat.
What changed
EPS beat consensus by 38.8% with reported $1.31 versus $0.94 estimate, shares fell 2.3%.
What the price now assumes
Market is pricing skepticism on growth and margin sustainability despite EPS beat, shown by share price decline.
What it means for the business
Maintain a cautious stance. watch for revenue and EPS growth inflection within next 90 days to reassess.
The next one to three months, as we saw it then
Better case25%
Revenue and EPS growth improve, margins stabilize, validating valuation discount and driving share price higher.
Base case50%
Growth remains weak but stable. valuation discount persists. shares trade sideways with modest volatility.
Worse case25%
Growth deteriorates further, margins compress, leverage concerns intensify, leading to share price decline.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Consider entry if revenue growth turns positive and operating margin exceeds 3%. avoid if leverage rises or EPS declines.
Scenario odds are a judgement, not measured.